Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736495) titled 'Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis' on July 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).

Primary Sponsor: Ain Shams University

Condition: Colorectal Cancer

Intervention: Drug: alpha lipoic acid 600 mg twice daily

Recruitment Status: Recruiting

Phase: Phase 2/Phase 3

Date of First Enrollment: July 27, 2026

Target Sample Size: 50

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07736495

Disclaimer: Curated ...